Clinical trial
Administration of Growth Hormone to Increase CD4+ Count in Patients Taking…
NCT00050921 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00050921 |
|---|---|
| Title | Administration of Growth Hormone to Increase CD4+ Count in Patients Taking Anti-HIV Drugs |
| Official title | Improving Immune Reconstitution With Growth Hormone in HIV-infected Subjects With Incomplete CD4+ Lymphocyte Restoration on Highly Active Antiretroviral Therapy (HAART) |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Biological, Drug |
| Interventions | somatropin, Hepatitis A virus, inactivated, Keyhole-Limpet Hemocyanin |
| Enrollment | 60 |
| Completion | Mar 1, 2005 |
| First posted | Jan 1, 2003 |
| Last update posted | Nov 1, 2021 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: